A carregar...
A Fatal Case of Pembrolizumab-Induced Myocarditis in Non–Small Cell Lung Cancer
Immune channel inhibitor–induced myocarditis is rare, and its management is challenging. Recently, guidelines were established for all ICIs, yet they do not take into account individual drug toxicities or screening protocols for prevention. We present a rare case of rapidly progressive pembrolizumab...
Na minha lista:
| Publicado no: | JACC Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8311714/ https://ncbi.nlm.nih.gov/pubmed/34317255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.12.045 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|